Medical News

RSS

PDGFRA gene may lead to effective treatments for paediatric high grade glioma: Study

Scientists have discovered a gene that could lead to more effective treatments for a form of childhood brain cancer called paediatric high grade glioma.

21 May 2010

Researchers analyze impact of health promotion program on cardiovascular disease-related medical, hospital costs

A comprehensive health promotion program reduced cardiovascular disease-related medical and hospital costs, according to a new study. CSX Transportation, a national company with 30,000 employees, developed the program in 2004 to address employees' high rates of cardiovascular disease when compared to national benchmarks and the associated higher healthcare costs.

21 May 2010

Axis Three announces availability of new XS-400 scanner for face, breast and body procedures

Axis Three, the leader and pioneer of 3D surgical simulation tools for aesthetic consultations, today announced the availability of its new XS-400 scanner, a turnkey system designed to address face, breast, and body procedures. The only 4-position 3D scanner on the market, the elegant XS-400 captures anatomically-accurate, 3D images of a patient's face or body, and serves as a vehicle to extend Axis Three's unrivaled simulation platform to an even broader range of cosmetic procedures.

21 May 2010

African-Americans, Hispanics less likely to meet MTM eligibility requirements: Study

Medicare's Part D prescription medication management program, also known as Medication Therapy Management, could be off limits to some of the patients who need it most — older African-Americans and Hispanics — a new study finds.

21 May 2010

CTT's Calmare Pain Therapy Treatment decreases pain associated with CIPN

Competitive Technologies, Inc. today announced the issuance of an abstract from a study which has shown the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy using CTT's Calmare Pain Therapy Treatment.

21 May 2010

Lack of discussion on resuming sex after heart attack associated with less sexual activity

Sexual activity declines in the year after heart attack for patients who don't get instructions from their doctors about when it's safe to resume sex, researchers reported at the American Heart Association's 11th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

21 May 2010

New data on ARIAD's AP24534 and ridaforolimus accepted for presentation at ASCO 2010

ARIAD Pharmaceuticals, Inc. today announced that new data on AP24534, its investigational pan-BCR-ABL inhibitor, and ridaforolimus, its investigational mTOR inhibitor being developed by Merck, Sharpe & Dohme Corp., have been accepted for presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting.

21 May 2010

Oberthur Technologies, SMART Association to offer smart card-centric ID solution to hospitals in North America

Oberthur Technologies, a global leader in the delivery of high security solutions and the #1 provider of smart credentials to the U.S. Federal government, has teamed up with one of healthcare's leading smart card software providers, SMART Association Inc., to offer a powerful, proven and secure, physical and logical access smart card-based admissions solution to hospitals and clinics throughout North America.

21 May 2010

Lantheus Medical Imaging receives additional supply of Mo-99 for production of vital medical isotopes

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that it has received additional supply of molybdenum-99 (Mo-99) to produce vital medical isotopes for its TechneLite® (Technetium Tc99m Generator) generators as the result of a recent agreement between the Institute for Radioelements (IRE), Fleurus, Belgium, and the Nuclear Research Institute (NRI), Rez, Czech Republic.

21 May 2010

PLC Systems' RenalGuard to be showcased at EuroPCR 2010

PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate RenalGuard® at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), May 25-28, 2010, in Paris, France. More than 11,000 clinicians and professionals are expected to attend this event.

21 May 2010

Updates on Micromet's BiTE antibody development programs to be made at two medical conferences

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that updates on several of its BiTE antibody development programs will be made at two upcoming medical conferences.

21 May 2010

New England Peptide launches NEPTune line of custom proteomics reagents

New England Peptide (NEP) today introduced NEPTune TM, a new proprietary line of custom proteomics reagents to help its customers to quickly and inexpensively maximize biomarker assay development and produce consistent results.

21 May 2010

Dr. Reddy's Laboratories launches tacrolimus capsules in the US market

Dr. Reddy's Laboratories today announced that it has launched tacrolimus capsules, (0.5mg, 1mg, 5mg), a bioequivalent generic version of Prograf Capsules, in the US market on May 20, 2010. The United States Food & Drug Administration granted an approval of Dr. Reddy's ANDA for tacrolimus capsules on May 13, 2010.

21 May 2010

Vitacost.com announces expansion of operations in North Carolina

Vitacost.com, Inc., a leading online retailer and direct marketer of health and wellness products, today announced the groundbreaking for the expansion of its east coast manufacturing and distribution facility in Lexington, North Carolina.

21 May 2010

US Department of Commerce honors Cyanotech with Export Achievement Certificate Award

Cyanotech Corporation has received an Export Achievement Certificate Award from the US Department of Commerce. The award is determined by the Hawaii Export Assistance Center of the department. It was presented by Hawaii Governor Linda Lingle, together with John Holman, Director of the Hawaii Export Assistance Center, U.S. Department of Commerce, at the Hawaii State Capitol in Honolulu.

21 May 2010

ImmunoCellular Therapeutics to present clinical results of ICT-107 dendritic cell immunotherapy at 46th ASCO

ImmunoCellular Therapeutics, Ltd. a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it will be presenting results from its clinical trial of ICT-107 at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8 in Chicago.

21 May 2010

Clinical data evaluating CAL-101 in patients with hematologic malignancies to be presented at ASCO 2010

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase inhibitors for the treatment of cancer and inflammatory diseases, today announced that updated clinical data evaluating CAL-101, an oral, PI3K inhibitor, in patients with hematologic malignancies, will be presented during a poster discussion session at the 2010 American Society of Clinical Oncology Annual Meeting taking place June 4-8, 2010 at McCormick Place in Chicago, IL.

21 May 2010

Eli Lilly to honor individuals with Welcome Back Award for improving lives of others

Despite years of debilitating depression, multiple psychiatric hospitalizations and episodes of homelessness, Joseph Rogers refused to let mental illness and an unlucky adolescence blot out his potential imprint on the world. Despite once being branded unemployable, Joseph relishes his role as advocate, embracing the challenges of being a change agent in mental health legislation, and pioneering the peer-run services movement.

21 May 2010

China BCT Pharmacy reports 5.2% increase in first-quarter 2010 revenue

China BCT Pharmacy Group, Inc., a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced results for the first quarter ended March 31, 2010.

21 May 2010

Ligand Pharmaceuticals secures milestone and royalty interest in IL-9 antibody program

Ligand Pharmaceuticals Incorporated announced today that it has purchased from the Genaera Liquidating Trust certain intellectual property and interests in future milestones and royalties for MEDI-528, an IL-9 antibody program under development by AstraZeneca's subsidiary, MedImmune. MEDI-528 is currently in a 320-patient Phase II study for moderate-to-severe asthma.

21 May 2010

Medical News

PDGFRA gene may lead to effective treatments for paediatric high grade glioma: Study

Researchers analyze impact of health promotion program on cardiovascular disease-related medical, hospital costs

Axis Three announces availability of new XS-400 scanner for face, breast and body procedures

African-Americans, Hispanics less likely to meet MTM eligibility requirements: Study

CTT's Calmare Pain Therapy Treatment decreases pain associated with CIPN

Lack of discussion on resuming sex after heart attack associated with less sexual activity

New data on ARIAD's AP24534 and ridaforolimus accepted for presentation at ASCO 2010

Oberthur Technologies, SMART Association to offer smart card-centric ID solution to hospitals in North America

Lantheus Medical Imaging receives additional supply of Mo-99 for production of vital medical isotopes

PLC Systems' RenalGuard to be showcased at EuroPCR 2010

Updates on Micromet's BiTE antibody development programs to be made at two medical conferences

New England Peptide launches NEPTune line of custom proteomics reagents

Dr. Reddy's Laboratories launches tacrolimus capsules in the US market

Vitacost.com announces expansion of operations in North Carolina

US Department of Commerce honors Cyanotech with Export Achievement Certificate Award

ImmunoCellular Therapeutics to present clinical results of ICT-107 dendritic cell immunotherapy at 46th ASCO

Clinical data evaluating CAL-101 in patients with hematologic malignancies to be presented at ASCO 2010

Eli Lilly to honor individuals with Welcome Back Award for improving lives of others

China BCT Pharmacy reports 5.2% increase in first-quarter 2010 revenue

Ligand Pharmaceuticals secures milestone and royalty interest in IL-9 antibody program

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News